Skip to main content

and
  1. Article

    Open Access

    The risk of thrombo-embolic events is increased in patients with germ-cell tumours and can be predicted by serum lactate dehydrogenase and body surface area

    The aim of this study was to evaluate the risk of thrombo-embolic events (TEE) in patients with germ-cell tumours (GCT) who receive cisplatin-based chemotherapy, to compare this risk to that of a matched contr...

    A-C Piketty, A Fléchon, A Laplanche, E Nouyrigat, J-P Droz in British Journal of Cancer (2005)